Skip to main content

Spyros Kalams Archives

Clinical Trials Unit lands major grant renewal

Feb. 11, 2021—Vanderbilt University Medical Center and Washington University School of Medicine in St. Louis have received renewal of a major federal grant to continue their collaboration to test and develop new treatments and vaccines against HIV/AIDS — and now COVID-19.

Read more


HERO-TOGETHER study seeks health care workers who receive COVID-19 vaccine

Dec. 21, 2020—Health care workers, who have been disproportionately affected by the COVID-19 pandemic, will be the first tier of Vanderbilt University Medical Center employees to receive vaccine to prevent SARS-CoV-2 infection.

Read more


Major international study testing therapy to prevent spread of HIV

Oct. 5, 2017—Nine more volunteers are needed to complete a study at Vanderbilt University Medical Center (VUMC) that could lead to a way to prevent the spread of HIV (human immunodeficiency virus).

Read more


Flu vaccine response in older adults

Jan. 25, 2017—High dose flu vaccine boosts the immune response in older adults by increasing activation of certain immune cells.

Read more


First subject enrolled in international HIV prevention study

Apr. 14, 2016—This month an international HIV prevention trial was launched that is testing the infection-preventing prowess of a monoclonal antibody called VRCO1.

Read more


AIDS Clinical Trials Unit lands renewal of NIH funding

Jan. 30, 2014—Vanderbilt University’s AIDS Clinical Trials Unit (ACTU) has received a seven-year grant renewal from the National Institutes of Health (NIH).

Read more


HIV’s impact on B cells

Jan. 15, 2014—Understanding how HIV infection affects immune system B cells may guide strategies for vaccine development.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more